IEYYX | RSLBX | IEYYX / RSLBX | |
Total Expense Ratio | 1.24 | 1.75 | 71% |
Annual Report Gross Expense Ratio | 1.43 | 1.75 | 82% |
Fund Existence | 19 years | 23 years | - |
Gain YTD | 7.056 | 7.989 | 88% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 98M | 79.4B | 0% |
Annual Yield % from dividends | 0.85 | 0.06 | 1,455% |
Returns for 1 year | 1.39 | 11.77 | 12% |
Returns for 3 years | -3.67 | 22.36 | -16% |
Returns for 5 years | 129.64 | 8.08 | 1,604% |
Returns for 10 years | -19.49 | 34.35 | -57% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JSVAX | 29.06 | 0.17 | +0.59% |
Janus Henderson Contrarian T | |||
BRXTX | 16.08 | N/A | N/A |
MFS Blended Research Intl Eq R3 | |||
PHPIX | 23.47 | N/A | N/A |
ProFunds Pharmaceuticals UltraSector Inv | |||
ADCCX | 17.79 | N/A | N/A |
American Century Disciplined Growth C | |||
BSGIX | 15.69 | N/A | N/A |
Baird Small/Mid Cap Growth Institutional |